Skip to main content
ARIX BIOSCIENCE PLC logo

ARIX BIOSCIENCE PLC — Investor Relations & Filings

Ticker · ARIX ISIN · GB00BD045071 LEI · 213800OVT3AHQCXNIX43 IL Financial and insurance activities
Open in API
Filings indexed 547 across all filing types
Latest filing 2018-04-23 Earnings Release
Country GB United Kingdom
Listing IL ARIX

About ARIX BIOSCIENCE PLC

https://www.arixbioscience.com/

Arix Bioscience plc is a global venture capital company that specializes in the biotechnology and life sciences sectors. The firm's primary activity involves investing in and building innovative biotech companies, providing capital and strategic support from early stages, including seed, preclinical, and clinical development. Arix focuses on identifying and nurturing breakthrough advances in life sciences to accelerate the development of new medical technologies and therapies. According to public information, the company has entered into a process of liquidation.

Recent filings

Filing Released Lang Actions
Annual Results 2017
Earnings Release Classification · 1% confidence The document is an 'Annual Results 2017' announcement from Arix Bioscience plc. It contains highlights, a Chairman's statement, and a CEO's statement. While it provides significant narrative and summary financial data, it is structured as an RNS (Regulatory News Service) announcement rather than the full, audited Annual Report (10-K). It serves as the initial release of the annual results, which is characteristic of an Earnings Release (ER) or a summary announcement of annual results. Given the specific category 'Earnings Release' (ER) is defined as the 'initial announcement of quarterly/periodical financial results', this fits perfectly. FY 2017
2018-04-23 English
Notice of Annual Results
Report Publication Announcement Classification · 1% confidence The document is a short announcement dated April 16, 2018, titled 'Notice of Annual Results and analyst briefing'. It explicitly states that the company 'will announce its annual results for the period ended 31 December 2017 on Monday 23 April 2018.' It also mentions details for an analyst briefing. Because the document is short and serves only to announce the future publication date and details of the annual results (rather than being the full annual report itself), it fits the definition of a Report Publication Announcement (RPA). The presence of 'RNS Number' suggests it was also distributed via the Regulatory News Service, but RPA is more specific to the content's purpose.
2018-04-16 English
Arix to present at HC Wainwright on 10 April
Regulatory Filings Classification · 1% confidence The document is very short (1954 characters) and announces that the CEO of Arix Bioscience will present at an external conference (H.C. Wainwright & Co. Global Life Sciences Conference) on a specific date. It explicitly mentions that a webcast will be accessible live and available for replay on the company's website. This structure—announcing participation in an event where information will be shared, rather than containing the detailed financial report itself—fits the definition of a Report Publication Announcement (RPA) or, given the RNS header, potentially a general Regulatory Filing (RNS). Since it is an announcement about future presentation/information dissemination, RPA is a strong candidate, but RNS is the general regulatory announcement category used by the LSE for such news items, as indicated by the 'RNS Number' and 'This information is provided by RNS' footer. Given the context of an LSE filing announcing an event, RNS is the most appropriate general regulatory category.
2018-04-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields detailing the 'acquisition or disposal of voting rights' by a person subject to notification (Ruffer LLP), crossing a threshold (5%). This type of mandatory disclosure regarding changes in significant share ownership directly corresponds to the definition of Major Shareholding Notification. The RNS Number confirms it is a regulatory filing, but the specific content points directly to the MRQ category, not the general RNS fallback.
2018-04-04 English
Total Voting Rights
Regulatory Filings Classification · 1% confidence The document is very short (1064 characters) and is explicitly identified as an 'RNS Number'. It announces the 'Total Voting Rights' as of a specific date (31 March 2018) and states the total number of shares in issue (134,764,018). This type of mandatory disclosure regarding share capital structure and voting rights, especially when issued via the RNS system, fits best under the category related to voting rights or general regulatory announcements. Since there is a specific category for 'Declaration of Voting Results & Voting Rights Announcements' (DVA), this is the most precise fit, as the core information is the total voting rights count. Although it is an RNS, DVA is more specific than the general RNS fallback.
2018-04-04 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with an 'RNS Number' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content is a mandatory regulatory filing concerning share ownership thresholds, making MRQ the most precise classification over the general RNS fallback.
2018-03-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.